Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas
Clinical trial NCT03732495 · UNKNOWN
Trial details
- NCT number
- NCT03732495
- Sponsor
- Centre Leon Berard
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-26
- Primary completion
- 2022-12-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.